<DOC>
	<DOCNO>NCT01511783</DOCNO>
	<brief_summary>The purpose single-center , randomize , double-blind , placebo-controlled , study evaluate safety , tolerability , pharmacokinetics , pharmacodynamics E2609 administer healthy elderly subject .</brief_summary>
	<brief_title>Evaluation Safety , Pharmacokinetics , Pharmacodynamics Multiple Doses E2609 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Key Healthy male female Female subject must nonchildbearing potential Aged 50 85 year , inclusive BMI 18 32 kg/m2 screen Thyroid function test within normal rangeMiniMental State Examination score 2830 , inclusive Key History neurological abnormality , include seizure Any clinically significant abnormality ECG Screening Baseline include QTc prolongation History ischemic heart disease , cardiac arrhythmia , cerebrovascular diseases Other medical condition stably control Presence orthostatic hypotension</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>